Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
7.14
-0.44 (-5.80%)
At close: Mar 13, 2026, 4:00 PM EDT
7.02
-0.12 (-1.67%)
After-hours: Mar 13, 2026, 7:56 PM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $589.57 million as of March 13, 2026. Its market cap has decreased by -39.41% in one year.
Market Cap
589.57M
Enterprise Value
396.78M
1-Year Change
-39.41%
Ranking
Category
Stock Price
$7.14
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $589.57M, an increase of 26.11%. That is a compound annual growth rate of 3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 589.57M | -22.68% |
| Dec 31, 2025 | 762.47M | -18.18% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 650.72M |
| LB Pharmaceuticals | 649.43M |
| Alpha Tau Medical | 631.03M |
| Tectonic Therapeutic | 625.45M |
| Design Therapeutics | 624.12M |
| Eikon Therapeutics | 618.66M |
| MeiraGTx Holdings | 594.83M |
| Zevra Therapeutics | 585.94M |